Entry Detail



General Information

Database ID:exR0090269
RNA Name:hsa-miR-671-5p
RNA Type:miRNA
Chromosome:chr7
Starnd:+
Coordinate:
Start Site(bp):151238449End Site(bp):151238471
External Links:hsa-miR-671-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
RCOR1
chr14
102592649
102730561
+
KIAA0232
chr4
6781375
6884170
+
TAF8
chr6
42050513
42087461
+
MAFG
chr17
81918270
81927735
-
DYRK1A
chr21
37365573
37526358
+
MED22
chr9
133338312
133348131
-
KLC1
chr14
103561896
103714249
+
CBX6
chr22
38861422
38872249
-
SAMD4B
chr19
39342396
39385710
+
GTSE1
chr22
46296870
46330810
+
SETD5
chr3
9397615
9479240
+
CREG1
chr1
167529117
167553805
-
IRS2
chr13
109752695
109786583
-
SCAMP3
chr1
155255979
155262430
-
CCDC6
chr10
59788747
59906556
-
BAZ2A
chr12
56595596
56636816
-
WDR82
chr3
52254434
52288020
-
TOMM6
chr6
41787662
41789898
+
FAM219A
chr9
34398184
34458570
-
STAT3
chr17
42313324
42388568
-
UHRF1BP1
chr6
34792015
34883138
+
AL365205.1
chr6
41780349
41790141
+
NACC1
chr19
13116862
13141147
+
SMAD3
chr15
67063763
67195169
+
WDTC1
chr1
27234632
27308636
+
IL1R1
chr2
102064544
102179874
+
PTPRU
chr1
29236516
29326813
+
GLYR1
chr16
4803203
4847288
-
APLP2
chr11
130068147
130144811
+
CHTF8
chr16
69118010
69132578
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC067930.1
chr8
143579636
143580670
+
AC145207.5
chr17
81878425
81881106
-
AL022311.1
chr22
37876148
37895563
+
AL137127.1
chr1
19072110
19075511
-
H19
chr11
1995176
2001470
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC01278
chrX
63222993
63561095
-
MIR29B2CHG
chr1
207801518
207879115
-
NEAT1
chr11
65422774
65445540
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.